Article citationsMore>>

Birkett, L., Dhar, S., Singh, P. and Mosahebi, A. (2022) Botulinum Toxin a in the Management of Acne Vulgaris: Evidence and Recommendations. Aesthetic Surgery Journal, 42, NP507-NP509.
https://doi.org/10.1093/asj/sjac037

has been cited by the following article:

• TITLE: Prospective Evaluation of Intradermal Botulinum Toxin Type A Microinjections for Sebum Reduction and Acne Improvement in Adults: A Single-Centre Interventional Study

  AUTHORS: Maryna Spivak

  KEYWORDS: Botulinum Toxin Type A, Intradermal Microinjections, Acne Vulgaris, Seborrhoea, Sebum Reduction, Microtoxin, Aesthetic Dermatology

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.14 No.11, October 30, 2026

  ABSTRACT: Sebum overproduction is a key factor in acne vulgaris and seborrhea. This prospective, single-center, interventional study evaluated the efficacy and safety of standardized intradermal microinjections of botulinum toxin type A (BoNT-A) in 42 adults with mild-to-moderate facial acne and seborrhea. Participants received 40 - 60 units of onabotulinumtoxin A via microdroplet technique. Outcomes included sebum levels (Sebumeter), acne lesion counts, patient satisfaction (Visual Analogue Scale [VAS] and Global Aesthetic Improvement Scale [GAIS]), and adverse events. After treatment, sebum production was observed to decrease by 47.9% at 4 weeks and 35.2% at 12 weeks (p